ESC 2015 Schedule: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 97: | Line 97: | ||
=== 9:30 AM === | === 9:30 AM === | ||
* '''Interviewee: '''Takeshi Kimura | * '''Interviewee: ''' Dr. Takeshi Kimura | ||
* '''Topic: '''ABSORB Japan: 12-month clinical and 13-month angiographic outcomes from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs. metallic drug-eluting stent | * '''Topic: '''ABSORB Japan: 12-month clinical and 13-month angiographic outcomes from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs. metallic drug-eluting stent | ||
* '''Embrago Lift: '''Tuesday, September 1st at 5:06 PM | * '''Embrago Lift: '''Tuesday, September 1st at 5:06 PM | ||
=== 10:00 AM === | === 10:00 AM === | ||
* '''Interviewee:''' Gérard Helft | * '''Interviewee:''' Dr. Gérard Helft | ||
* '''Topic: '''The OPTIDUAL trial: 12 vs 48 months of clopidogrel after drug-eluting stent placement | * '''Topic: '''The OPTIDUAL trial: 12 vs 48 months of clopidogrel after drug-eluting stent placement | ||
* '''Embargo Lift: '''Monday, August 31st at 12:12 PM | * '''Embargo Lift: '''Monday, August 31st at 12:12 PM | ||
| Line 156: | Line 156: | ||
=== 4:30 PM ''(PENDING)'' === | === 4:30 PM ''(PENDING)'' === | ||
* '''Interviewee:''' Dr. | * '''Interviewee:''' Dr. Gerasimos Filippatos | ||
* '''Topic:''' Finerenone versus eplerenone in patients with worsening chronic heart failure with type 2 diabetes mellitus and/or chronic kidney disease: main results of the ARTS-HF trial | * '''Topic:''' Finerenone versus eplerenone in patients with worsening chronic heart failure with type 2 diabetes mellitus and/or chronic kidney disease: main results of the ARTS-HF trial | ||
* '''Embrago Lift: '''Monday, August 31st at 11:18 AM | * '''Embrago Lift: '''Monday, August 31st at 11:18 AM | ||
Revision as of 16:03, 9 July 2015
Here is the page we will use to coordinate the TV events at ESC 2015. Open time slots are indicated below in red.
Filming Location: Crowne Plaza London - Dockland, Western Gateway, Royal Victoria Dock, London, E16 1AL, United Kingdom
Click on Date for Detailed Schedule
Monday, August 31, 2015
8:00 AM
OPEN TIME SLOT
8:30 AM
- Interviewee:Dr. Vivek Reddy
- Topic:Safety and efficacy of a Leadless pacemaker: results from the LEADLESS II clinical trial
- Embargo Lift: Sunday, August 30th at 5:38 PM
9:00 AM
OPEN TIME SLOT
9:30 AM
- Interviewee: Dr. Kazuaki Kaitani (and Dr. Atsushi Kobori)
- Topic: Efficacy of Antiarrhythmic drugs Short-Term use after catheter ablation for Atrial Fibrillation (EAST-AF) Trial AND Efficacy of adenosine triphosphate guided ablation for atrial fibrillation: UNmasking Dormant Electrical Reconduction by Adenosine TriPhosphate (UNDER-ATP) Trial
- Embargo Lift: Sunday, August 30th at 4:30 PM and Sunday, august 30th at 4:30 PM
10:00 AM
- Interviewee:Pr. Michel Ovize
- Topic:Does cyclosporine improve clinical outcomes in STEMI patients? The CIRCUS trial
- Embargo Lift: Sunday, August 30th, at 12:27 PM
10:30 AM (PENDING)
- Interviewee:Dr. Luigi Di Biase
- Topic:Effect of empirical left atrial appendage isolation on long-term procedure outcome in patients with long-standing persistent atrial fibrillation undergoing catheter ablation: results from the BELIEF Trial
- Embargo Lift:Sunday August 30th, at 4:53 PM
11:00 AM
OPEN TIME SLOT
11:30 AM (PENDING)
- Interviewee:Dr. Morris Brown
- Topic:Principal results from Prevention And Treatment of Hypertension With Algorithm based therapY (PATHWAY): comparison of single and combination diuretics in essential hypertension - PATHWAY-3
- Embargo Lift:Monday August 31st at 5:16 PM
12:00 PM
OPEN TIME SLOT
12:30 PM
OPEN TIME SLOT
1:00 PM
OPEN TIME SLOT
1:30 PM
OPEN TIME SLOT
2:00 PM
OPEN TIME SLOT
2:30 PM
- Interviewee: Dr. Dirk Westermann
- Topic: Accurate and rapid diagnosis of myocardial infarction using a high sensitivity Troponin I 1-hour algorithm
- Embargo Lift: Sunday, August 30th at 11:00 AM
3:00 PM
- Interviewee:Dr. Basil Lewis
- Topic: ESC 2015 Wrap-up in Hebrew
3:30 PM
- Interviewee:Dr. Renato Lopes
- Topic: ESC 2015 Wrap-up in Portuguese
4:00 PM
- Interviewee:Pr. Freek Verheugt
- Topic: ESC 2015 Wrap-up from the Perspective of the Netherlands
4:30 PM
OPEN TIME SLOT
Tuesday, September 1, 2015
8:00 AM
OPEN TIME SLOT
8:30 AM
OPEN TIME SLOT
9:00 AM
OPEN TIME SLOT
9:30 AM
- Interviewee: Dr. Takeshi Kimura
- Topic: ABSORB Japan: 12-month clinical and 13-month angiographic outcomes from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs. metallic drug-eluting stent
- Embrago Lift: Tuesday, September 1st at 5:06 PM
10:00 AM
- Interviewee: Dr. Gérard Helft
- Topic: The OPTIDUAL trial: 12 vs 48 months of clopidogrel after drug-eluting stent placement
- Embargo Lift: Monday, August 31st at 12:12 PM
10:30 AM
- Interviewee: Dr. Pamela Douglas
- Topic: Outcomes of an FFRCT diagnostic strategy versus usual care in suspected coronary artery disease: results from the PLATFORM (Prospective LongitudinAl Trial of FFRCT: Outcome and Resource IMpacts) study
- Embargo Lift: Tuesday, September 1st at 4:30 PM
11:00 AM
- Interviewee: Dr. Hisao Ogawa
- Topic: A trial of Telmisartan prevention of cardiovascular diseases (ATTEMPT-CVD) : the large biomarkers study with 1228 patients AND ESC 2015 Wrap-up in Japanese
- Embargo Lift: Monday August 31st at 4:30 PM
11:30 AM
OPEN TIME SLOT
12:00 PM
OPEN TIME SLOT
12:30 PM
OPEN TIME SLOT
1:00 PM
- Interviewee: Dr. Gregg Stone
- Topic: Peri-infarct zone pacing to prevent adverse left ventricular remodeling in patients with very large myocardial infarction
- Embargo Lift: Sunday, August 30th at 11:54 AM
1:30 PM
- Interviewee: Dr. Patrick Serruys
- Topic: Everolimus-eluting bioresorbable vascular scaffolds versus durable polymer everolimus-eluting metallic stents in patients with acute myocardial infarction. Results of the ABSORB STEMI TROFI II trial.
- Embargo Lift: Tuesday, September 1st at 4:48 PM
2:00 PM
- Interviewee: Dr. Gerasimos Filippatos
- Topic: Finerenone versus eplerenone in patients with worsening chronic heart failure with type 2 diabetes mellitus and/or chronic kidney disease: main results of the ARTS-HF trial
- Embargo Lift: Monday, August 31st at 11:18 AM
2:30 PM
OPEN TIME SLOT
3:00 PM
OPEN TIME SLOT
3:30 PM (PENDING)
- Interviewee: Dr. Carlos A. Morillo
- Topic: The BENznidazole Evaluation For Interrupting Trypanosomiasis trial
- Embargo Lift: Tuesday, September 1st at 12:08 PM
4:00 PM
- Interviewee: Dr. Dr. Stefan James (and guest Dr. Jonas Oldgren)
- Topic: Wrap-up from a Scandinavian Perspective
4:30 PM (PENDING)
- Interviewee: Dr. Gerasimos Filippatos
- Topic: Finerenone versus eplerenone in patients with worsening chronic heart failure with type 2 diabetes mellitus and/or chronic kidney disease: main results of the ARTS-HF trial
- Embrago Lift: Monday, August 31st at 11:18 AM
5:00 PM - 6:00 PM
- Interviewee: Pr. Gilles Montalescot
- Topic: Early aldosterone blockade in acute myocardial infarction: the randomized ALBATROSS Trial AND Assessment of an education and guidance program for apixaban adherence in non-valvular atrial fibrillation: the randomized AEGEAN study AND ESC 2015 Wrap-up in French
- Embargo Lift: Sunday, August 30th at 11:36 AM (ALBATROSS) and Sunday, August 30th at 5:16 PM (AEGEAN)